Prospect Hill Growth Partners is a private equity firm specializing in control equity investments. The firm typically engages in Series A, Series B, and other undisclosed investment rounds, focusing on sectors such as education, biotechnology, and healthcare. Their investment size varies, with notable investments including $30.5 million in EdisonLearning, $61.5 million in Pyramid Biosciences, and $20.7 million in VeraDermics.
The firm boasts a robust portfolio featuring companies like EdisonLearning, Pyramid Biosciences, and VeraDermics. Key partners and decision-makers at Prospect Hill Growth Partners bring extensive experience and industry connections to the table, enhancing their investment philosophy centered around strategic growth and operational excellence. They offer unique value-add services to portfolio companies, including strategic guidance, operational support, and access to a broad network of industry experts.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.